Development of in situ gel containing asiaticoside/cyclodextrin complexes. Evaluation in culture human periodontal ligament cells (HPLDCs).

Asiaticoside Collagen type I Cyclodextrin Encapsulation In situ gel Periodontitis

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
30 Aug 2020
Historique:
received: 07 04 2020
revised: 25 06 2020
accepted: 26 06 2020
pubmed: 8 7 2020
medline: 22 6 2021
entrez: 8 7 2020
Statut: ppublish

Résumé

Asiaticoside (AS), an active herbal compound isolated from Centella asiatica, has the potential benefit in promoting type I collagen (COL I) synthesis and osteogenic differentiation in human periodontal ligament cells (HPDLCs). However, it has low aqueous solubility which may hamper the bioavailability. Thus, the aim of this study was to develop thermoresponsive in situ gel containing AS/cyclodextrin (CD) complexes. The non-encapsulated formulations consisted of AS/hydroxypropyl β-CD (HPβCD) complexes and encapsulated formulations containing AS loaded sulfobutylether β-CD/chitosan nanoparticles (SBEβCD/CS NPs) were prepared. The appearance, pH and viscosity of all formulations were within the acceptable range. All formulations formed relatively rapid sol-to-gel transition when contacted with simulated salivary fluid at body temperature. Compared to non-encapsulated formulations, in vitro gelation and rheological studies of encapsulated formulations displayed gel formation that remained longer with high mechanical strength. In vitro mucoadhesion and in vitro release studies revealed that nanoencapsulated in situ gel had excellent mucoadhesive property and could release AS in a sustained manner. These formulations exhibited no cytotoxic effects to HPDCLs. The SBEβCD/CS NPs containing low AS content could express the COL I synthesis. Thus, nanoencapsulated platform could serve as a promising carrier to deliver AS for periodontal tissue regeneration.

Identifiants

pubmed: 32634457
pii: S0378-5173(20)30573-1
doi: 10.1016/j.ijpharm.2020.119589
pii:
doi:

Substances chimiques

Cyclodextrins 0
Triterpenes 0
Chitosan 9012-76-4
asiaticoside PKO39VY215

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119589

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Hay Man Saung Hnin Soe (HMSH)

Faculty of Pharmaceutical Sciences, Chulalongkorn University, 254 Phyathai rd., Pathumwan, Bangkok 10330, Thailand.

Jittima Amie Luckanagul (JA)

Faculty of Pharmaceutical Sciences, Chulalongkorn University, 254 Phyathai rd., Pathumwan, Bangkok 10330, Thailand.

Prasit Pavasant (P)

Faculty of Dentistry, Chulalongkorn University, 34 Henri-Dunant Rd., Pathumwan, Bangkok 10330, Thailand.

Phatsawee Jansook (P)

Faculty of Pharmaceutical Sciences, Chulalongkorn University, 254 Phyathai rd., Pathumwan, Bangkok 10330, Thailand. Electronic address: phatsawee.j@chula.ac.th.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH